Ligand Pharmaceuticals (LGND) Operating Margin (2010 - 2026)
Ligand Pharmaceuticals (LGND) operating margin from Jun 30, 2010 to Mar 31, 2026. The current Ligand Pharmaceuticals (LGND) operating margin is 33.58%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of Ligand Pharmaceuticals (LGND)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | 15.29% | -213.05% |
| 2024 | -13.53% | -248.78% |
| 2023 | 9.09% | +487.01% |
| 2022 | 1.55% | -96.40% |
| 2021 | 42.99% | N/A |
| 2021 | 0.00% | N/A |
| 2021 | 0.00% | N/A |
| 2021 | 0.00% | -100.00% |
| 2020 | 22.93% | N/A |
| 2020 | 0.00% | N/A |
| 2020 | 0.00% | N/A |
| 2020 | 0.00% | -100.00% |
| 2019 | 671.00% | N/A |
| 2019 | 0.00% | N/A |
| 2019 | 0.00% | N/A |
| 2019 | 0.00% | -100.00% |
| 2018 | 65.11% | N/A |
| 2018 | 0.00% | N/A |
| 2018 | 0.00% | N/A |
| 2018 | 0.00% | -100.00% |
| 2017 | 48.25% | N/A |
| 2017 | 0.00% | N/A |
| 2017 | 0.00% | N/A |
| 2017 | 0.00% | -100.00% |
| 2016 | 40.28% | N/A |
| 2016 | 0.00% | N/A |
| 2016 | 0.00% | N/A |
| 2016 | 0.00% | -100.00% |
| 2015 | 38.01% | N/A |
| 2015 | 0.00% | N/A |
| 2015 | 0.00% | N/A |
| 2015 | 0.00% | -100.00% |
| 2014 | 30.42% | N/A |
| 2014 | 0.00% | N/A |
| 2014 | 0.00% | N/A |
| 2014 | 0.00% | -100.00% |
| 2013 | 30.51% | N/A |
| 2013 | 30.51% | N/A |
| 2013 | 0.00% | N/A |
| 2013 | 0.00% | N/A |
| 2013 | 0.00% | -100.00% |
| 2012 | 0.61% | -56.55% |
| 2012 | 1.39% | N/A |
| 2012 | 0.00% | N/A |
| 2012 | 0.00% | N/A |
| 2012 | 0.00% | -100.00% |
| 2011 | -5.41% | +84.66% |
| 2011 | -2.93% | N/A |
| 2011 | 0.00% | N/A |
| 2011 | 0.00% | N/A |
| 2011 | 0.00% | -100.00% |
| 2010 | -124.47% | N/A |
| 2010 | -124.47% | +386.14% |
| 2009 | -25.60% | N/A |
| 2009 | -25.60% | N/A |
Comparison Ligand Pharmaceuticals (LGND) operating margin with competitors
Ligand Pharmaceuticals (LGND) operating margin is 33.58%.